Authors: Xu Jianming, Zhang Mingzhi DOI: 10.3760/cma.j.cn115989-20220518-00224 Published 2023-12-10 Cite as Chin J Exp Ophthalmol, 2023, 41(12): 1221-1226. Abstract [Download PDF] [Read Full Text] Primary open-angle glaucoma (POAG) is an irreversible blinding eye disease that severely threatens and damages the optic nerve […]
Tag: Metabolomics
A systematic review of metabolomic studies on the mechanism of myopia
Authors: Liu Shang, Xiong Shuyu, He Xiangui DOI: 10.3760/cma.j.cn115989-20200613-00429 Published 2023-04-10 Cite as Chin J Exp Ophthalmol, 2023, 41(4): 392-397. Abstract [Download PDF] [Read Full Text] Myopia has become a global public health concern with its increasing prevalence.It is the interaction result […]
Paying attention to the application of proteomics and metabolomics in clinical and translational research of diabetic retinopathy
Authors: Zhang Hui, Li Xiaorong, Zhou Lei DOI: 10.3760/cma.j.cn115989-20220831-00406 Published 2022-09-10 Cite asChin J Exp Ophthalmol, 2022, 40(9): 791-795. Abstract [View PDF] [Read Full Text] Diabetic retinopathy (DR) is one of the complications of diabetic mellitus and a major cause of blindness […]
The opportunities of metabolic windows for early diagnosis and precise prevention and treatment of diabetic retinopathy
Authors: Zhang Fang, Xu Xun DOI: 10.3760/cma.j.cn115989-20211209-00678 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 1-5. Abstract [View PDF] [Read Full Text] Diabetes mellitus (DM) is a chronic metabolic disease caused by multiple etiologies. Diabetic retinopathy (DR), as a primary ocular […]
Research progress of metabolomics in diabetic retinopathy
Authors: Zhang Luyuan, Li Xiaorong DOI: 10.3760/cma.j.cn115989-20201203-00819 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 93-96. Abstract [View PDF][Read Full Text] Diabetic retinopathy (DR) is one of the serious complications of diabetes, and its complex pathogenesis has not been completely clarified […]